Randomized placebo controlled human pharmacology study· 1994
Growth hormone-releasing activity of hexarelin in humans
Imbimbo BP, Mant T, Edwards M, et al.
European Journal of Clinical Pharmacology
- PubMed
- 7957536
- Evidence level
- low_to_moderate
- Verification
- verified
Summary
Double-blind placebo-controlled rising-dose study of intravenous hexarelin in healthy male volunteers.
Limitations
Only 12 participants, single-dose exposure and biomarker endpoints. Long-term benefit and safety were not assessed.